-
Must Watch These 5 Stocks: Cambrex (NYSE:CBM), The Home Depot (NYSE:HD), Advanced Micro Devices (NASDAQ:AMD), International Business Machines (NYSE:IBM), Palatin Technologies (NYSEMKT:PTN)
Zacks upgraded shares of Cambrex Corporation (NYSE:CBM) from a neutral rating to an outperform rating in a research note released on Thursday morning. They currently have $35.40 target price on the stock. On Wednesday shares of Cambrex Corporation. (NYSE:CBM) closed at $33.97. Company’s sales growth for last 5 years was 9.80% and EPS growth for…
-
Don’t Miss These Stocks: Terex Corporation (NYSE:TEX), Oracle Corporation (NYSE:ORCL), Agios Pharmaceuticals (NASDAQ:AGIO), Cambrex Corporation. (NYSE:CBM), Emerson Electric Co. (NYSE:EMR)
Terex Corporation (NYSE: TEX) announced its Board of Directors approved a quarterly dividend increase to its shareholders. The new quarterly cash dividend of $0.06 per share is an increase of 20% over the 2014 quarterly dividend amount. The dividend will be made on March 19, 2015 to shareholders of record as of March 10, 2015.On…
-
Morning Movers: The Coca-Cola Company (NYSE:KO), Nuverra Environmental Solutions (NYSE:NES), AT&T (NYSE:T), Cambrex Corporation. (NYSE:CBM), Yandex N.V. (NASDAQ:YNDX)
The Coca-Cola Company (NYSE:KO) has reported a 54.97percent plunge in profit for the quarter ended Dec. 31, 2014. The company has earned $770 million, or $0.17 a share in the quarter, compared with $1,710 million, or $0.38 a share for the same period last year. On Tuesday shares of The Coca-Cola Company (NYSE:KO) closed at…
-
Top Movers: Cambrex Corporation. (NYSE:CBM), Meru Networks (NASDAQ:MERU), Brightcove Inc. (NASDAQ:BCOV), Baytex Energy Corp. (NYSE:BTE), Coty Inc. (NYSE:COTY)
On February 6, Cambrex Corporation. (NYSE:CBM) announced that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continued growth in demand for the Company’s active pharmaceutical ingredient (API) contract manufacturing capabilities is driving the need for more capacity. On Tuesday shares of Cambrex Corporation. (NYSE:CBM)…
-
Market Alert: Oracle Corporation (NYSE:ORCL), Regulus Therapeutics (NASDAQ:RGLS), PartnerRe (NYSE:PRE), Credit Suisse Asset Management Income Fund Inc. (NYSEMKT:CIK), Cambrex (NYSE:CBM)
Oracle Corporation (NYSE:ORCL) paid more than $1.2 billion to acquire marketing analytics company Datalogix Holdings Inc., according to two people familiar with the situation. Oracle announced its intent to buy Datalogix on Dec. 22, without disclosing the purchase price. The deal closed on Jan. 23, according to Datalogix’s website. On Monday shares of Oracle Corporation…
-
Hot Runners: Cambrex Corporation. (NYSE:CBM), Canadian Solar Inc. (NASDAQ:CSIQ), Journal Communications Inc. (NYSE:JRN), Meritor (NYSE:MTOR), JDS Uniphase Corporation (NASDAQ:JDSU)
Cambrex Corporation. (NYSE:CBM) announced that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continued growth in demand for the Company’s active pharmaceutical ingredient (API) contract manufacturing capabilities is driving the need for more capacity. On Friday shares of Cambrex Corporation. (NYSE:CBM) closed at $30.01.…
-
Trader’s Buzz: Cambrex Corporation. (NYSE:CBM), LiqTech International (NYSEMKT:LIQT), InspireMD (NYSEMKT:NSPR), Cellcom Israel (NYSE:CEL), Career Education Corp. (NASDAQ:CECO)
Cambrex Corporation. (NYSE:CBM) reports results for the fourth quarter and full year ended December 31, 2014. Fourth quarter 2014 sales increased 25% to $128.8 million from $103.0 million in the same period last year. Full year 2014 sales increased 18%, and 19% excluding the impact of foreign currency. On Friday shares of Cambrex Corporation. (NYSE:CBM)…
-
Biotech Stocks Touched New Highs: Cambrex Corporation. (NYSE:CBM), Biogen Idec Inc. (NASDAQ:BIIB), Coherus Biosciences (NASDAQ:CHRS), ImmuCell (NASDAQ:ICCC), Esperion Therapeutics (NASDAQ:ESPR)
Cambrex Corporation. (NYSE:CBM) reported Fourth quarter 2014 sales increased 25% to $128.8 million from $103.0 million in the same period last year. Full year 2014 sales increased 18%, and 19% excluding the impact of foreign currency. On Friday shares of Cambrex Corporation. (NYSE:CBM) closed at $30.01. Company’s sales growth for last 5 years was 5.00%…
-
Biotech Gainers in Spotlight: Genetic Technologies Limited (NASDAQ:GENE), Cambrex Corporation. (NYSE:CBM), Portola Pharmaceuticals (NASDAQ:PTLA), Coherus Biosciences (NASDAQ:CHRS), Vericel Corporation (NASDAQ:VCEL)
On 29 January, Genetic Technologies Limited (NASDAQ: GENE) reported that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in…
-
Traders Buzz: TrueBlue (NYSE:TBI), Cambrex Corporation. (NYSE:CBM), Ascent Solar Technologies (NASDAQ:ASTI), Bristol-Myers Squibb Company (NYSE:BMY), Ford Motor Company (NYSE:F)
On 5 February, TrueBlue, Inc. (NYSE:TBI) announced that revenue for the fourth quarter of 2014 was $691 million, an increase of 54 percent, compared to revenue of $449 million for the fourth quarter of 2013. Net income for the fourth quarter of 2014 was $0.65 per diluted share, compared to $0.36 for the fourth quarter…